Inefficacy of bortezomib therapy for CNS involvement of refractory multiple myeloma. [electronic resource]
- Leukemia research May 2007
- 721-3 p. digital
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
0145-2126
10.1016/j.leukres.2006.06.019 doi
Antineoplastic Agents--therapeutic use Boronic Acids--therapeutic use Bortezomib Brain Neoplasms--drug therapy Humans Male Middle Aged Multiple Myeloma--drug therapy Neoplasm Recurrence, Local Pyrazines--therapeutic use Treatment Failure